Sep 20, 2023 8:30am EDT Inhibikase Therapeutics Issues a Letter to Shareholders and Comments on Recent Trading Activity
Aug 24, 2023 8:30am EDT Inhibikase Therapeutics Announces Development of Novel Formulation of risvodetinib